本页面由Tiger Trade Technology Pte. Ltd.提供服务

Amylyx Pharmaceuticals

13.85
-0.2500-1.77%
盘后13.850.00000.00%16:11 EST
成交量:114.68万
成交额:1,595.21万
市值:15.31亿
市盈率:-9.05
高:14.37
开:13.82
低:13.67
收:14.10
52周最高:17.49
52周最低:3.11
股本:1.11亿
流通股本:6,544.94万
量比:0.80
换手率:1.75%
股息:- -
股息率:- -
每股收益(TTM):-1.5305
每股收益(LYR):-1.5305
净资产收益率:-61.59%
总资产收益率:-36.41%
市净率:5.02
市盈率(LYR):-9.05

数据加载中...

2026/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/03

重要事件披露

Form 8-K - Current report
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities